Effective refractory period
Effective refractory period (ERP) is a term used in cardiology to describe the period of time during which a cardiac cell or tissue is unable to respond to a second stimulus, regardless of its strength. This period is critical in preventing arrhythmia and maintaining the normal rhythm of the heart.
Physiology
The effective refractory period is a part of the cardiac cycle, which is the sequence of events that occur when the heart beats. The ERP begins immediately after the depolarization of the cardiac cell and lasts until the cell is almost completely repolarized.
During the ERP, the cardiac cell is in a state of hyperpolarization, which means that it is more negatively charged than its resting state. This is due to the outflow of potassium ions from the cell. The cell is unable to respond to a second stimulus during this period because the ion channels that allow for depolarization are inactivated.
Clinical significance
The effective refractory period is important in preventing the occurrence of arrhythmias. If a second stimulus occurs before the end of the ERP, it can cause a premature contraction, which can lead to an abnormal heart rhythm.
In certain conditions, such as ischemic heart disease or heart failure, the ERP can be altered. This can increase the risk of developing arrhythmias.
Measurement
The effective refractory period can be measured using electrophysiology techniques. This involves the use of a catheter to deliver a series of electrical stimuli to the heart, and then measuring the response. The ERP is the interval between the first stimulus and the first response that fails to produce a contraction.
See also
- Absolute refractory period
- Relative refractory period
- Cardiac action potential
- Cardiac electrophysiology

This article is a cardiovascular system stub. You can help WikiMD by expanding it!
Ad. Transform your life with W8MD's Budget GLP-1 injections from $49.99


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $49.99 for the starting dose of Semaglutide and $65.00 for Tirzepatide.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
